Artiva Biotherapeutics, Inc. ARTV Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s software and technology licenses, net?
- Artiva Biotherapeutics, Inc. (ARTV) reported software and technology licenses, net of $458K in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Artiva Biotherapeutics, Inc.'s software and technology licenses, net increased by 3423.1% year-over-year, from $13K to $458K.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s software and technology licenses, net?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s software and technology licenses, net has grown at a 8.1% compound annual growth rate (CAGR), from $392K to $458K.